Luspatercept: A peaceful revolution in the standard of care for myelodysplastic neoplasms.

Autor: Vinchi F; Iron Research Laboratory New York Blood Center New York New York USA.; Weill Cornell Medicine Department of Pathology and Laboratory Medicine New York New York USA., Platzbecker U; Universitatsklinikum Leipzig Klinik und Poliklinik fur Hamatologie Zelltherapie und Hamostaseologie Leipzig Germany.
Jazyk: angličtina
Zdroj: HemaSphere [Hemasphere] 2024 Mar 03; Vol. 8 (3), pp. e41. Date of Electronic Publication: 2024 Mar 03 (Print Publication: 2024).
DOI: 10.1002/hem3.41
Abstrakt: Competing Interests: Francesca Vinchi: Silence Therapeutics: Research Funding; CSL Vifor: Research Funding; PharmaNutra: Research Funding; RallyBio: Consultancy. Uwe Platzbecker: Janssen: Honoraria; Jazz: Honoraria; Silence Therapeutics: Honoraria; Takeda: Honoraria; Novartis: Honoraria; Abbvie: Honoraria; BMS/Celgene: Honoraria; Geron: Honoraria.
Databáze: MEDLINE